These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2479771)

  • 41. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
    Zhang Y; Chapman JH; Ulcay A; Sutton RE
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.
    Bachelder RE; Bilancieri J; Lin W; Letvin NL
    J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection.
    Peudenier S; Hery C; Montagnier L; Tardieu M
    Ann Neurol; 1991 Feb; 29(2):152-61. PubMed ID: 1707249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor.
    Collman R; Godfrey B; Cutilli J; Rhodes A; Hassan NF; Sweet R; Douglas SD; Friedman H; Nathanson N; Gonzalez-Scarano F
    J Virol; 1990 Sep; 64(9):4468-76. PubMed ID: 2200889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diminution of CD4 surface protein but not CD4 messenger RNA levels in monocytic cells infected by HIV-1.
    Geleziunas R; Bour S; Boulerice F; Hiscott J; Wainberg MA
    AIDS; 1991 Jan; 5(1):29-33. PubMed ID: 2059359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    Callahan LN; Phelan M; Mallinson M; Norcross MA
    J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.
    Devico A; Silver A; Thronton AM; Sarngadharan MG; Pal R
    Virology; 1996 Apr; 218(1):258-63. PubMed ID: 8615032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.
    Trkola A; Pomales AB; Yuan H; Korber B; Maddon PJ; Allaway GP; Katinger H; Barbas CF; Burton DR; Ho DD
    J Virol; 1995 Nov; 69(11):6609-17. PubMed ID: 7474069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of gamma-interferon on the expression of major histocompatibility complex class I and II gene products in neural cells isolated from the developing human fetal peripheral nervous system.
    Kollas BB; Hartle HT; Wigdahl B
    Fetal Diagn Ther; 1992; 7(2):62-74. PubMed ID: 1380249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line.
    Harouse JM; Collman RG; González-Scarano F
    J Virol; 1995 Dec; 69(12):7383-90. PubMed ID: 7494242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudotypes of vesicular stomatitis virus-bearing envelope antigens of certain HIV-1 strains permissively infect human syncytiotrophoblasts cultured in vitro: implications for in vivo infection of syncytiotrophoblasts by cell-free HIV-1.
    Bácsi A; Ebbesen P; Szabó J; Beck Z; Andirkó I; Csoma E; Tóth FD
    J Med Virol; 2001 Aug; 64(4):387-97. PubMed ID: 11468721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection.
    Alsmadi O; Herz R; Murphy E; Pinter A; Tilley SA
    J Virol; 1997 Feb; 71(2):925-33. PubMed ID: 8995609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphocytotropic strains of HIV type 1 when complexed with enhancing antibodies can infect macrophages via Fc gamma RIII, independently of CD4.
    Trischmann H; Davis D; Lachmann PJ
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):343-52. PubMed ID: 7540399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
    Dey B; Del Castillo CS; Berger EA
    J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
    Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
    Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins.
    He Y; D'Agostino P; Pinter A
    Vaccine; 2003 Oct; 21(27-30):4421-9. PubMed ID: 14505925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.
    Chen BK; Gandhi RT; Baltimore D
    J Virol; 1996 Sep; 70(9):6044-53. PubMed ID: 8709227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4.
    Diamond DC; Finberg R; Chaudhuri S; Sleckman BP; Burakoff SJ
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5001-5. PubMed ID: 2142306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.